GlassScriptPhysician profile
Brian N Schwartz
NPI 1851483713
$20,438.09
in general payments reported to CMS, 2019-2025
48 companies · $5,310 in 2025
The $5,310 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $231 · 2021: $7,995 · 2022: $3,166 · 2023: $909 · 2024: $1,954 · 2025: $5,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,848 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Debt Forgiveness: $1,236 · Travel and Lodging: $1,014 · Education: $75.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,847.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Debt Forgiveness | $1,236.23 |
| Travel and Lodging | $1,013.74 |
| Education | $75.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $7,807.47 | 2019-2025 | |
| Avyxa Pharma, LLC | $3,201.85 | 2025 | |
| Valencia Technologies Corporation | $2,592.94 | 2022 | |
| Olympus America INC. | $1,272.55 | 2022-2024 | Oes Cystonephrofiberscope, Itind System |
| Procept Biorobotics Corporation | $435.99 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Janssen Biotech, INC. | $423.18 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $411.99 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $376.31 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $374.30 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $276.96 | 2019-2024 | Edex, Aveed, Xiaflex |
| Coloplast Corp | $244.79 | 2019-2023 | Self-Cath, Speedicath, Porges Coloplast |
| Endo USA, INC. | $240.74 | 2024-2025 | Xiaflex, Aveed, Edex |
| Dendreon Pharmaceuticals LLC | $224.12 | 2019-2025 | Provenge |
| Teleflex LLC | $190.66 | 2021-2025 | Barrigel, Urolift |
| Blue Earth Diagnostics | $187.00 | 2019-2023 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $178.92 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $169.67 | 2022-2025 | Jelmyto |
| Nalu Medical, INC. | $149.58 | 2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $144.28 | 2019-2025 | Spaceoar System, Lithovue |
| Tolmar, INC. | $136.27 | 2024-2025 | Eligard |
| Antares Pharma, INC. | $109.96 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Mission Pharmacal Company | $109.02 | 2021-2024 | Uribel, Uribel Tabs |
| Laborie Medical Technologies Corp. | $98.51 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Novartis Pharmaceuticals Corporation | $93.07 | 2022-2025 | |
| Rochester Medical Corporation | $90.86 | 2019 | |
| Progenics Pharmaceuticals, INC. | $88.92 | 2023-2025 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $88.68 | 2021-2022 | |
| Abbvie INC. | $66.24 | 2022-2025 | Botox |
| Bioprotect Medical, INC. | $60.44 | 2025 | Bioprotect Balloon Implant System |
| Immunitybio, INC. | $60.10 | 2024-2025 | |
| Urovant Sciences INC | $58.19 | 2021-2022 | |
| Myovant Sciences INC. | $57.41 | 2021-2022 | |
| Telix Pharmaceuticals | $45.46 | 2025 | Illuccix |
| C. R. Bard, INC. & Subsidiaries | $44.31 | 2022 | |
| Acerus Pharmaceuticals Corporation | $37.21 | 2021 | |
| Merck Sharp & Dohme LLC | $36.89 | 2023 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Myriad Genetic Laboratories, INC. | $32.59 | 2021-2023 | Myrisk |
| Abc Home Medical Supply, INC. | $31.51 | 2025 | |
| Neotract INC. | $29.77 | 2019 | |
| Angiodynamics, INC. | $22.01 | 2025 | Nanoknife |
| Bluewind Medical | $19.31 | 2025 | |
| Ambu INC. | $19.22 | 2025 | |
| Isoray, INC | $14.17 | 2022 | |
| Calyxo, INC. | $14.16 | 2025 | Cvac Aspiration System |
| Allergan, INC. | $13.32 | 2019 | |
| Amgen INC. | $12.57 | 2019 | |
| Clarus Therapeutics INC. | $9.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.